Felice Ho‐Ching Tsang

5.0k total citations · 3 hit papers
29 papers, 3.8k citations indexed

About

Felice Ho‐Ching Tsang is a scholar working on Molecular Biology, Cancer Research and Spectroscopy. According to data from OpenAlex, Felice Ho‐Ching Tsang has authored 29 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 16 papers in Cancer Research and 2 papers in Spectroscopy. Recurrent topics in Felice Ho‐Ching Tsang's work include Epigenetics and DNA Methylation (9 papers), RNA modifications and cancer (9 papers) and Cancer-related molecular mechanisms research (8 papers). Felice Ho‐Ching Tsang is often cited by papers focused on Epigenetics and DNA Methylation (9 papers), RNA modifications and cancer (9 papers) and Cancer-related molecular mechanisms research (8 papers). Felice Ho‐Ching Tsang collaborates with scholars based in Hong Kong, China and United States. Felice Ho‐Ching Tsang's co-authors include Chun‐Ming Wong, Irene Oi‐Lin Ng, Carmen Chak‐Lui Wong, Lai Wei, Cheuk‐Ting Law, Joyce Man‐Fong Lee, David Kung‐Chun Chiu, Jialing Shen, Daniel Wai‐Hung Ho and Sandy Leung–Kuen Au and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Felice Ho‐Ching Tsang

29 papers receiving 3.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

RNA N6‐methyladenosine methyltransferase‐like 3 promotes liver cancer progression through YTHDF2‐dependent posttranscriptional silencing of SOCS2

2017 1.0k citations Mengnuo Chen, Lai Wei et al. Hepatology profile →
Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications

2018 350 citations Chun‐Ming Wong, Felice Ho‐Ching Tsang et al. Nature Reviews Gastroenterology & Hepatology profile →
Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC

2019 297 citations Lai Wei, Derek Lee et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Felice Ho‐Ching Tsang Hong Kong	22	3.1k	2.0k	503	361	310	29	3.8k
Joyce Man‐Fong Lee Hong Kong	27	3.0k 1.0×	2.0k 1.0×	594 1.2×	279 0.8×	269 0.9×	42	3.9k
David Kung‐Chun Chiu Hong Kong	21	2.2k 0.7×	1.4k 0.7×	743 1.5×	655 1.8×	367 1.2×	36	3.3k
Cheuk‐Ting Law Hong Kong	17	2.1k 0.7×	1.1k 0.6×	307 0.6×	126 0.3×	221 0.7×	20	2.4k
Qingguang Liu China	32	1.9k 0.6×	1.4k 0.7×	466 0.9×	182 0.5×	196 0.6×	67	2.7k
Dawei Rong China	23	1.8k 0.6×	1.4k 0.7×	598 1.2×	509 1.4×	546 1.8×	35	2.8k
Naohiro Nishida Japan	30	2.6k 0.8×	2.2k 1.2×	776 1.5×	147 0.4×	307 1.0×	72	3.6k
Seung-Oe Lim United States	15	1.8k 0.6×	969 0.5×	1.6k 3.3×	843 2.3×	546 1.8×	17	3.4k
Lo‐Kong Chan Hong Kong	24	1.2k 0.4×	794 0.4×	486 1.0×	262 0.7×	238 0.8×	42	1.9k
Li Zhou China	32	1.5k 0.5×	1.0k 0.5×	905 1.8×	314 0.9×	297 1.0×	118	2.7k
Antonella Papa United States	18	2.4k 0.8×	560 0.3×	855 1.7×	247 0.7×	390 1.3×	29	3.1k

Countries citing papers authored by Felice Ho‐Ching Tsang

Since Specialization

Citations

This map shows the geographic impact of Felice Ho‐Ching Tsang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Felice Ho‐Ching Tsang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Felice Ho‐Ching Tsang more than expected).

Fields of papers citing papers by Felice Ho‐Ching Tsang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Felice Ho‐Ching Tsang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Felice Ho‐Ching Tsang. The network helps show where Felice Ho‐Ching Tsang may publish in the future.

Co-authorship network of co-authors of Felice Ho‐Ching Tsang

This figure shows the co-authorship network connecting the top 25 collaborators of Felice Ho‐Ching Tsang. A scholar is included among the top collaborators of Felice Ho‐Ching Tsang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Felice Ho‐Ching Tsang. Felice Ho‐Ching Tsang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tsang, Felice Ho‐Ching, et al.. (2024). The characteristics of CTCF binding sequences contribute to enhancer blocking activity. Nucleic Acids Research. 52(17). 10180–10193. 4 indexed citations

Wei, Lai, Gengchao Wang, Cheuk‐Ting Law, et al.. (2022). In Vivo Genome-Wide CRISPR Activation Screening Identifies Functionally Important Long Noncoding RNAs in Hepatocellular Carcinoma. Cellular and Molecular Gastroenterology and Hepatology. 14(5). 1053–1076. 12 indexed citations

Shen, Jialing, Mengnuo Chen, Derek Lee, et al.. (2019). Histone chaperone FACT complex mediates oxidative stress response to promote liver cancer progression. Gut. 69(2). 329–342. 42 indexed citations

Wei, Lai, Derek Lee, Cheuk‐Ting Law, et al.. (2019). Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC. Nature Communications. 10(1). 4681–4681. 297 indexed citations breakdown →

Law, Cheuk‐Ting, Lai Wei, Felice Ho‐Ching Tsang, et al.. (2018). HELLS Regulates Chromatin Remodeling and Epigenetic Silencing of Multiple Tumor Suppressor Genes in Human Hepatocellular Carcinoma. Hepatology. 69(5). 2013–2030. 59 indexed citations

Tsang, Felice Ho‐Ching, David Kung‐Chun Chiu, Misty Shuo Zhang, et al.. (2018). Hepatitis transactivator protein X promotes extracellular matrix modification through HIF/LOX pathway in liver cancer. Oncogenesis. 7(5). 44–44. 35 indexed citations

Wong, Chun‐Ming, Felice Ho‐Ching Tsang, & Irene Oi‐Lin Ng. (2018). Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications. Nature Reviews Gastroenterology & Hepatology. 15(3). 137–151. 350 indexed citations breakdown →

Chiu, David Kung‐Chun, Aki Pui‐Wah Tse, Mingjing Xu, et al.. (2017). Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma. Nature Communications. 8(1). 517–517. 342 indexed citations

Lee, Derek, Mingjing Xu, David Kung‐Chun Chiu, et al.. (2017). Folate cycle enzyme MTHFD1L confers metabolic advantages in hepatocellular carcinoma. Journal of Clinical Investigation. 127(5). 1856–1872. 110 indexed citations

10.

Wei, Lai, David Kung‐Chun Chiu, Felice Ho‐Ching Tsang, et al.. (2017). Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3. Journal of Hepatology. 67(4). 758–769. 123 indexed citations

11.

Tsang, Felice Ho‐Ching, Sandy Leung–Kuen Au, Lai Wei, et al.. (2015). MicroRNA-142-3p and microRNA-142-5p are downregulated in hepatocellular carcinoma and exhibit synergistic effects on cell motility. Frontiers of Medicine. 9(3). 331–343. 47 indexed citations

12.

Wong, Carmen Chak‐Lui, Yanping Huang, Yanting Zhu, et al.. (2014). Lysyl oxidase-like 2 is critical to tumor microenvironment and metastatic niche formation in hepatocellular carcinoma. Hepatology. 60(5). 1645–1658. 205 indexed citations

13.

Tsang, Felice Ho‐Ching, Sandy Leung–Kuen Au, Lai Wei, et al.. (2014). Long non‐coding RNA HOTTIP is frequently up‐regulated in hepatocellular carcinoma and is targeted by tumour suppressive miR‐125b. Liver International. 35(5). 1597–1606. 126 indexed citations

14.

Wong, Carmen Chak‐Lui, Carmen Chak‐Lui Wong, Sandy Leung–Kuen Au, et al.. (2014). Switching of Pyruvate Kinase Isoform L to M2 Promotes Metabolic Reprogramming in Hepatocarcinogenesis. PLoS ONE. 9(12). e115036–e115036. 66 indexed citations

15.

Tsang, Felice Ho‐Ching, et al.. (2014). Expression of ankyrin repeat and SOCS box containing 4 (ASB4) confers migration and invasion properties of hepatocellular carcinoma cells. BioScience Trends. 8(2). 101–110. 19 indexed citations

16.

Tsang, Felice Ho‐Ching, Wenjing Lü, Felix H. Shek, et al.. (2014). Prognostic Marker MicroRNA-125b Inhibits Tumorigenic Properties of Hepatocellular Carcinoma Cells Via Suppressing Tumorigenic Molecule eIF5A2. Digestive Diseases and Sciences. 59(10). 2477–2487. 41 indexed citations

17.

Fan, Dorothy Ngo-Yin, Felice Ho‐Ching Tsang, Sandy Leung–Kuen Au, et al.. (2012). Histone Lysine Methyltransferase, Suppressor of Variegation 3-9 Homolog 1, Promotes Hepatocellular Carcinoma Progression and Is Negatively Regulated by MicroRNA-125b. Hepatology. 57(2). 637–647. 95 indexed citations

18.

Fatima, Sarwat, Felice Ho‐Ching Tsang, Frank T. Kolligs, et al.. (2012). Dickkopf 4 (DKK4) acts on Wnt/β-catenin pathway by influencing β-catenin in hepatocellular carcinoma. Oncogene. 31(38). 4233–4244. 47 indexed citations

19.

Tsang, Felice Ho‐Ching, Nikki Lee, & John M. Luk. (2009). The Use of Small Peptides in the Diagnosis and Treatment of Hepatocellular Carcinoma. Protein and Peptide Letters. 16(5). 530–538. 4 indexed citations

20.

Hu, Meiyu, Kang–Da Liu, Sarwat Fatima, et al.. (2009). Proteomic Identification of a Monoclonal Antibody Recognizing Caveolin-1 in Hepatocellular Carcinoma with Metastatic Potential. Protein and Peptide Letters. 16(5). 479–485. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact